Ep0165 50490 — New York, New York

Ep0165 50490 is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ep0165 50490 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Stereotypical Prolonged Seizures.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ep0165 50490?

Ep0165 50490 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ep0165 50490 conducted?

Ep0165 50490 has 1 clinical trials on record, with 1 currently active. Their work covers Stereotypical Prolonged Seizures.

Is Ep0165 50490 accredited by Crixeo Health?

Ep0165 50490 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ep0165 50490?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.